HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christopher M Ward Selected Research

Platinum

6/2004An immediate hemolytic reaction induced by repeated administration of oxaliplatin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christopher M Ward Research Topics

Disease

8Neoplasms (Cancer)
07/2019 - 08/2002
7Thrombosis (Thrombus)
11/2021 - 05/2014
4Stroke (Strokes)
11/2020 - 11/2016
3Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
08/2022 - 10/2017
3Hemorrhage
11/2021 - 09/2005
3Thrombocytopenia (Thrombopenia)
01/2019 - 10/2015
3Neoplasm Metastasis (Metastasis)
11/2014 - 11/2003
3Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
07/2005 - 07/2004
2Ischemic Stroke
11/2020 - 12/2017
2Infections
07/2019 - 01/2018
2Bernard-Soulier Syndrome (Giant Platelet Syndrome)
12/2015 - 09/2005
2Cardiovascular Diseases (Cardiovascular Disease)
04/2015 - 02/2013
1Iron-Deficiency Anemia (Anemia, Iron Deficiency)
11/2021
1Nervous System Diseases (Neurological Disorders)
11/2020
1Infarction (Infarctions)
11/2020
1Inflammation (Inflammations)
07/2019
1Hemophilia A (Haemophilia)
07/2019
1MYH9-Related Disorders
12/2018
1Lichen Planus (Lichen Ruber Planus)
01/2018
1Brain Infarction
12/2017
1Polyps
01/2017
1Atrial Fibrillation
11/2016
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
11/2016
1Jacobsen Distal 11q Deletion Syndrome
10/2015
1Multiple Endocrine Neoplasia Type 2b (MEN 3)
10/2012
1Type 3 von Willebrand Disease
05/2012
1Carcinogenesis
01/2011
1DiGeorge Syndrome (Syndrome, DiGeorge)
12/2007
1Vascular Diseases (Vascular Disease)
10/2006
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
06/2006
1Hemolytic Anemia
06/2004
1Hemolysis
06/2004
1Carcinoma (Carcinomatosis)
11/2003

Drug/Important Bio-Agent (IBA)

5AntibodiesIBA
11/2021 - 01/2017
4Glycoproteins (Glycoprotein)IBA
10/2017 - 11/2003
4AntigensIBA
08/2005 - 08/2002
3Inosine Triphosphate (ITP)IBA
08/2022 - 10/2017
3Proteins (Proteins, Gene)FDA Link
12/2018 - 01/2011
3Cadherins (E-Cadherin)IBA
01/2017 - 01/2011
2CollagenIBA
12/2017 - 10/2015
2Glutamic Acid (Glutamate)FDA Link
09/2015 - 05/2014
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
04/2015 - 02/2013
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2006 - 06/2006
2Superoxide DismutaseIBA
05/2005 - 07/2004
2CopperIBA
05/2005 - 07/2004
2ZincIBA
05/2005 - 07/2004
1Hemostatics (Antihemorrhagics)IBA
07/2019
1Blood Coagulation Factors (Coagulation Factor)IBA
07/2019
1Heparin (Liquaemin)FDA LinkGeneric
01/2019
1Platelet Factor 4IBA
01/2019
1Myosin Heavy Chains (Myosin Heavy Chain)IBA
12/2018
1Mitochondrial DNA (mtDNA)IBA
01/2018
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2018
1AutoantibodiesIBA
12/2017
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
12/2017
1Monoclonal AntibodiesIBA
12/2017
1Glycine (Aminoacetic Acid)FDA LinkGeneric
12/2017
1Polytetrafluoroethylene (Teflon)FDA Link
01/2017
1AnticoagulantsIBA
11/2016
1ibrutinibIBA
11/2016
1Fibrinogen (Factor I)FDA Link
05/2016
1Nonsense Codon (Nonsense Mutation)IBA
12/2015
1A-Form DNA (A-DNA)IBA
10/2015
1FibrinIBA
04/2015
1ThrombinFDA Link
04/2015
1Oxygen (Dioxygen)IBA
10/2012
1Metalloproteases (Metalloproteinases)IBA
05/2012
1LigandsIBA
05/2012
1Cell Adhesion MoleculesIBA
01/2011
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2011
1Chemokine CXCL12IBA
04/2010
1Platelet Membrane GlycoproteinsIBA
12/2007
1Clopidogrel (Plavix)FDA Link
06/2006
1adhesion receptorIBA
09/2005
1Superoxide Dismutase-1IBA
07/2005
1PlatinumIBA
06/2004
1Complementary DNA (cDNA)IBA
08/2002

Therapy/Procedure

2Therapeutics
11/2016 - 06/2006
1Drug Therapy (Chemotherapy)
06/2004
1Immunotherapy
08/2002